The global biopharmaceutical industry is entering a new era. As technology, supply chains, and innovation ecosystems continue to evolve, the ability to translate scientific breakthroughs into scalable and reliable manufacturing has become more critical than ever.

From June 22–25, CATUG will participate in the BIO International Convention 2026 in San Diego, joining innovators, partners, and industry leaders from around the world to discuss the future of therapeutic development and industrialization.

Joining Cytiva's Executive Dialogue on Innovation

As part of BIO 2026, Dr. Aimee Wang, Co-founder and CEO of CATUG, has been invited to participate in a featured discussion hosted by Cytiva:

Changing Innovation Paradigms — A Navigator's Guide

June 23, 2026 | 10:30 AM PDT

Cytiva Booth #2027

Alongside leaders from Cytiva and AbCellera, the discussion will explore how platform collaboration, global technology transfer, and manufacturing readiness can help accelerate the development of next-generation therapeutics in an increasingly complex environment.

Exhibiting with HKSTP at BIO 2026

As a member company of the Hong Kong Science and Technology Parks Corporation (HKSTP), CATUG will also exhibit within the Hong Kong Pavilion.

Booth #2211

Through its integrated Plasmid–RNA–LNP–Fill & Finish CRDMO platform, CATUG continues to support global innovators with scalable CMC development and manufacturing solutions for advanced therapeutics.

From Innovation to Industrialization

Scientific innovation creates possibilities. Industrialization transforms them into reality.

At CATUG, we are committed to bridging that gap through engineering excellence, quality-driven execution, and globally aligned manufacturing capabilities. From plasmid DNA and RNA production to LNP formulation and aseptic fill-finish, our mission is to help innovative therapies move efficiently from concept to clinic and beyond.

We look forward to connecting with partners and innovators at BIO 2026.

Meet CATUG at Booth #2211.